JLE

Hépato-Gastro & Oncologie Digestive

Hépato-Gastro & Oncologie Digestive

Volume 29, supplement 4, August 2022

News from JFHOD 2022: Focus on immunotherapy in digestive cancers

AstrazenecaMSDNuméro réalisé avec le soutien institutionnel des laboratoires MSD et AstraZeneca

MENU

Volume 29, supplement 4, August 2022

Synthèse des communications

Article News in the management of oesogastric cancers (p.5-12)
David Sefrioui

Article Managment of hepatobiliary cancers (p.13-20)
Yann Touchefeu, Juliette Boilève

Article Current Knowledge on immunotherapy in digestive cancers (excluding HCC and biliary tract) at the time of the JFHOD 2022 (p.21-30)
Jean-Marc Phelip, Quentin Tournier, Nicolas Williet